Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Wall

Showing results (1051-1060 of 1,090) with videos related to

Pageof 109
Sort By:
Journal of Hepatology|July 30, 2010
A phase I clinical trial of dendritic cell immunotherapy in HCV-infected individualsEric J Gowans, Stuart Roberts, Kathryn Jones, et al.
Substance Use & Misuse|September 15, 2025
Cannabis Legalization and Cannabis Use Disorder by Sex in Veterans Health Administration Patients, 2005-2019Caroline G Wisell, Deborah S Hasin, Melanie M Wall, et al.
Plos Medicine|July 19, 2019
Correction: Discovery and validation of a prognostic proteomic signature for tuberculosis progression: A prospective cohort studyAdam Penn-Nicholson, Thomas Hraha, Ethan G Thompson, et al.
American Journal of Physiology. Endocrinology and Metabolism|July 16, 2015
Pendrin localizes to the adrenal medulla and modulates catecholamine releaseYoskaly Lazo-Fernandez, Greti Aguilera, Truyen D Pham, et al.
Clinical Journal of the American Society of Nephrology : CJASN|November 15, 2018
PTH, FGF23, and Intensive Blood Pressure Lowering in Chronic Kidney Disease Participants in SPRINTCharles Ginsberg, Timothy E Craven, Michel B Chonchol, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|May 14, 2020
Proof of mechanism and target engagement of glutamatergic drugs for the treatment of schizophrenia: RCTs of pomaglumetad and TS-134 on ketamine-induced psychotic symptoms and pharmacoBOLD in healthy volunteersJoshua T Kantrowitz, Jack Grinband, Donald C Goff, et al.
American Journal of Hypertension|October 7, 2017
Clinical Outcomes by Race and Ethnicity in the Systolic Blood Pressure Intervention Trial (SPRINT): A Randomized Clinical TrialCarolyn H Still, Carlos J Rodriguez, Jackson T Wright, et al.
Neuroimage. Clinical|March 11, 2019
A multicenter study of ketamine effects on functional connectivity: Large scale network relationships, hubs and symptom mechanismsLeah M Fleming, Daniel C Javitt, Cameron S Carter, et al.
The Journal of Clinical Investigation|April 15, 2010
The Na+-dependent chloride-bicarbonate exchanger SLC4A8 mediates an electroneutral Na+ reabsorption process in the renal cortical collecting ducts of miceFrançoise Leviel, Christian A Hübner, Pascal Houillier, et al.
Medical Research Archives|August 9, 2024
An Ultra-Brief Proxy Measure for Early Mental and Substance Use Disorders and Suicide Risk Case Detection at the Community and Household Level: An Efficient and Feasible Clinical and Population-level Service Needs Screening ToolMelissa A Stockton, Ernesha Webb Mazinyo, Lungelwa Mlanjeni, et al.
Pageof 109

Showing results (1051-1060 of 1,090) with videos related to

Sort By:
Pageof 109
Journal of Hepatology|July 30, 2010
A phase I clinical trial of dendritic cell immunotherapy in HCV-infected individualsEric J Gowans, Stuart Roberts, Kathryn Jones, et al.
Substance Use & Misuse|September 15, 2025
Cannabis Legalization and Cannabis Use Disorder by Sex in Veterans Health Administration Patients, 2005-2019Caroline G Wisell, Deborah S Hasin, Melanie M Wall, et al.
Plos Medicine|July 19, 2019
Correction: Discovery and validation of a prognostic proteomic signature for tuberculosis progression: A prospective cohort studyAdam Penn-Nicholson, Thomas Hraha, Ethan G Thompson, et al.
American Journal of Physiology. Endocrinology and Metabolism|July 16, 2015
Pendrin localizes to the adrenal medulla and modulates catecholamine releaseYoskaly Lazo-Fernandez, Greti Aguilera, Truyen D Pham, et al.
Clinical Journal of the American Society of Nephrology : CJASN|November 15, 2018
PTH, FGF23, and Intensive Blood Pressure Lowering in Chronic Kidney Disease Participants in SPRINTCharles Ginsberg, Timothy E Craven, Michel B Chonchol, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|May 14, 2020
Proof of mechanism and target engagement of glutamatergic drugs for the treatment of schizophrenia: RCTs of pomaglumetad and TS-134 on ketamine-induced psychotic symptoms and pharmacoBOLD in healthy volunteersJoshua T Kantrowitz, Jack Grinband, Donald C Goff, et al.
American Journal of Hypertension|October 7, 2017
Clinical Outcomes by Race and Ethnicity in the Systolic Blood Pressure Intervention Trial (SPRINT): A Randomized Clinical TrialCarolyn H Still, Carlos J Rodriguez, Jackson T Wright, et al.
Neuroimage. Clinical|March 11, 2019
A multicenter study of ketamine effects on functional connectivity: Large scale network relationships, hubs and symptom mechanismsLeah M Fleming, Daniel C Javitt, Cameron S Carter, et al.
The Journal of Clinical Investigation|April 15, 2010
The Na+-dependent chloride-bicarbonate exchanger SLC4A8 mediates an electroneutral Na+ reabsorption process in the renal cortical collecting ducts of miceFrançoise Leviel, Christian A Hübner, Pascal Houillier, et al.
Medical Research Archives|August 9, 2024
An Ultra-Brief Proxy Measure for Early Mental and Substance Use Disorders and Suicide Risk Case Detection at the Community and Household Level: An Efficient and Feasible Clinical and Population-level Service Needs Screening ToolMelissa A Stockton, Ernesha Webb Mazinyo, Lungelwa Mlanjeni, et al.
Pageof 109